PAPER Mollah SA, Nayak A, Barhai S, Maity U
SEARCH RESULTS
331386 RESULTS
PAPER Yang LX, Luo M, Li SY
Tanshinone IIA improves Alzheimer's disease via RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis.
World J Psychiatry. 2024 Apr 19;14(4):563-581. PubMed: 38659601Robert Sobolewski
Massachusetts General HospitalCharlestown, United States
Thomas Foltynie on Diabetes Drug Shows Promise for Parkinson’s Disease
COMMENT This is an important publication, given it essentially replicates the findings of Athauda et al., who reported positive Phase 2 data of a very similar GLP-1 receptor agonist drug, exenatide, when given to patients with Parkinson’s disease (Athauda et al.,
Oscar Mailman
Pittsburgh, United States
Nazaret Gamez
Houston Methodist Research InstituteHouston, United States
Sandrine Legg
Alchemab Therapeutics
Nigel Greig on Diabetes Drug Shows Promise for Parkinson’s Disease
COMMENT It is wonderful to see a treatment strategy, proposed by my collaborators and me in 2002 in publications describing the neuroprotective/neurotrophic actions of GLP-1 receptor agonists, demonstrating efficacy in Parkinson’s disease (Perry et al., 2002; Per
PAPER Chang CW, Tan CH, Hong WP, Yu RL
GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's disease.
J Neurol. 2024 Apr 24; PubMed: 38656622PAPER Cevik SE, Skaar DA, Jima DD, Liu AJ, Østbye T, Whitson HE, Jirtle RL, Hoyo C, Planchart A
DNA methylation of imprint control regions associated with Alzheimer's disease in non-Hispanic Blacks and non-Hispanic Whites.
Clin Epigenetics. 2024 Apr 25;16(1):58. PubMed: 38658973PAPER Soyer A, Goutal S, Leterrier S, Marie S, Larrat B, Selingue E, Winkeler A, Sarazin M, Bottlaender M, Tournier N
[18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET imaging repurposed for quantitative estimation of blood-brain barrier permeability in a rat model of Alzheimer's disease.
Ann Pharm Fr. 2024 Apr 22; PubMed: 38657857PAPER Ma Z, Zhang Z, Lv X, Zhang H, Lu K, Su G, Huang B, Chen H
Dual sensitivity-enhanced microring resonance-based integrated microfluidic biosensor for Aβ42 detection.
Talanta. 2024 Apr 16;275:126111. PubMed: 38657362PAPER Srivastava A, Kumar G, Kumar P, Srikrishna S, Chandra P, Singh VP
Thiazole-Based Silver Ion Sensor for Sequential Colorimetric Visualization of Epinephrine in the Brain Tissues of an Alzheimer's Disease Model of Mouse.
ACS Appl Bio Mater. 2024 Apr 23; PubMed: 38654595PAPER Zaafar D, Elghazawy NH, Hassan A, Mahmoud MY, Bakr AF, Arafa RK
Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies.
Int J Biol Macromol. 2024 Apr 21;268(Pt 1):131740. PubMed: 38653428PAPER Mey M, Bhatta S, Suresh S, Labrador LM, Piontkivska H, Casadesus G
Therapeutic benefits of central LH receptor agonism in the APP/PS1 AD model involve trophic and immune regulation and reproductive status dependent.
Biochim Biophys Acta Mol Basis Dis. 2024 Apr 21;:167165. PubMed: 38653355Current Filters
No filters selected